In a child with suspected Kawasaki disease who shows an elevated C‑reactive protein on day 2, what is the recommended management?

Management of Elevated CRP on Day 2 in Suspected Kawasaki Disease

If a child presents with fever and elevated CRP on day 2 with suspected Kawasaki disease, you should continue monitoring for additional clinical criteria while preparing for prompt IVIG treatment as soon as the diagnosis can be established—do not wait for all criteria to develop if the clinical picture is compelling.

Diagnostic Approach

The 2017 AHA guidelines provide a clear framework for this scenario 1:

• Complete KD requires fever ≥5 days plus ≥4 of the 5 principal clinical features (bilateral conjunctivitis, oral changes, rash, extremity changes, cervical lymphadenopathy)
• Incomplete KD should be suspected when fever ≥5 days with only 2-3 principal features

Critical Day 2 Considerations

On day 2, you are too early to meet the fever duration criterion (≥5 days). However, this is the time to:

1. Document all present clinical features systematically
2. Obtain baseline laboratory markers: ESR, CRP, complete blood count, albumin, ALT, AST
3. Perform baseline echocardiography if ≥3 clinical features are present or if laboratory markers suggest high inflammation
4. Monitor daily for evolution of additional clinical criteria

When to Treat Based on CRP Elevation

The elevated CRP on day 2 is significant because 1:

• CRP >3.0 mg/dL is one of the supplementary laboratory criteria supporting incomplete KD diagnosis
• Higher CRP levels correlate with increased risk of coronary artery abnormalities 2, 3
• The CRP/albumin ratio may predict both coronary lesions and IVIG resistance 2

Treatment Timing Algorithm

Treat with IVIG (2 g/kg) + aspirin when:

1. Complete KD criteria met (fever ≥5 days + ≥4 principal features) - treat immediately 1

2. Incomplete KD with high-risk features (fever ≥5 days + 2-3 principal features + elevated inflammatory markers including CRP >3.0 mg/dL + echocardiographic abnormalities) - treat immediately 1

3. Delayed diagnosis beyond day 10 with ongoing inflammation (CRP >3.0 mg/dL) and/or coronary abnormalities - still treat 1

Common Pitfalls to Avoid

Do not delay treatment waiting for "classic" presentation:

• The incomplete KD algorithm exists precisely because 15-25% of children don't develop all criteria 1
• Young infants are particularly prone to incomplete presentations and higher risk for coronary complications 4, 5

Do not dismiss elevated CRP as "just viral":

• CRP elevation in the context of persistent fever warrants systematic KD evaluation 2, 3
• The combination of male gender, incomplete presentation, elevated platelet count, and high CRP/albumin ratio significantly increases coronary artery lesion risk 2

Monitoring Strategy Days 2-5

While awaiting the 5-day fever threshold:

• Daily clinical assessment for evolving KD features
• Repeat inflammatory markers (CRP, ESR) if clinical suspicion increases
• Echocardiography if ≥3 features develop or if laboratory markers worsen
• Low threshold for treatment in high-risk patients (infants <6 months, males, those with very high CRP) 4, 5

Risk Stratification

Patients at highest risk who may benefit from early aggressive treatment include 4:

• Young infants (especially <6 months)
• Males
• Those with CRP/albumin ratio ≥2.94 2
• Presence of coronary changes at diagnosis
• Laboratory markers suggesting high inflammation (elevated WBC, low albumin, elevated liver enzymes)

The key principle: In view of the low risks of IVIG administration versus the high risks of untreated coronary aneurysms (15-25% without treatment), err on the side of treatment when clinical suspicion is high 1.